Abstract
Combined modality treatment (CMT) consisting of chemotherapy followed by localised radiotherapy is standard treatment for patients with early stage Hodgkin lymphoma (HL). However, due to long term adverse effects such as secondary malignancies, the role of radiotherapy has been questioned recently and some clinical study groups advocate chemotherapy only for this indication.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cochrane Database of Systematic Reviews |
Vol/bind | 2 |
Sider (fra-til) | CD007110 |
ISSN | 1469-493X |
DOI | |
Status | Udgivet - 1 jan. 2011 |